Browse Items (66 total)
- Tags: Pneumonia
A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
Tags: *Anti-Bacterial Agents/pharmacokinetics/therapeutic use, *Community-Acquired Infections/drug therapy/microbiology/physiopathology/prevention & control, *Models, *Pneumonia, 2009, Adelman Martin H, Aged, Area Under Curve, Bacterial/drug therapy/microbiology/physiopathology/prevention & control, Biological, Bronchitis, Chronic Obstructive/drug therapy/microbiology/*physiopathology, Chronic/drug therapy/microbiology/physiopathology, Department of Internal Medicine, Disease Progression, Female, File Thomas M Jr, Humans, International journal of antimicrobial agents, Klugman Keith P, Lavin Bruce, Lung Diseases/complications/drug therapy/microbiology, Lung/microbiology, Male, Microbial Sensitivity Tests, Middle Aged, Monte Scott V, NEOMED College of Medicine, Paladino Joseph A, Pneumococcal/drug therapy/microbiology/physiopathology/prevention & control, Pneumonia, Pulmonary Disease, Schentag Jerome J, Severity of Illness Index, Singer Mendel E, Streptococcus pneumoniae/*drug effects, Yu Victor L
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
Tags: *Levofloxacin, 1997, 80 and over, Administration, Adolescent, Adult, Aged, Anti-Infective Agents/adverse effects/*therapeutic use, Antimicrobial agents and chemotherapy, Bacterial/*drug therapy/microbiology, Ceftriaxone/adverse effects/*therapeutic use, Cefuroxime/adverse effects/*analogs & derivatives/therapeutic use, Cephalosporins/adverse effects/*therapeutic use, Combination, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, Drug Therapy, Dunbar L, Female, File T M Jr, Humans, Injections, Intravenous, Kohler R, Kojak C, Male, Middle Aged, NEOMED College of Medicine, Ofloxacin/adverse effects/*therapeutic use, Oral, Player R, Pneumonia, Prodrugs/adverse effects/*therapeutic use, Prospective Studies, Rubin A, Segreti J, Treatment Outcome, Williams R R
A new dosing paradigm: high-dose, short-course fluoroquinolone therapy for community-acquired pneumonia.
Tags: 2003, Clinical cornerstone, Community-Acquired Infections/*drug therapy, Department of Internal Medicine, File Thomas M Jr, Fluoroquinolones/*administration & dosage/pharmacology/therapeutic use, Humans, NEOMED College of Medicine, Ofloxacin/administration & dosage/pharmacology/therapeutic use, Pneumococcal/*drug therapy, Pneumonia, Safety, Time Factors, Treatment Outcome
A Structured Approach for Safely Reintroducing Bariatric Surgery in a COVID-19 Environment.
Tags: 2020, Adult, Aminian A, Augustin T, Bariatric Surgery, Bauman M, Bencsath KP, Betacoronavirus, Cha W, Clinical Protocols, Cohort Studies, complications, coronavirus, Coronavirus Infections/epidemiology/prevention & control, COVID-19, Daigle CR, Fathalizadeh A, Female, Hospital List, Humans, Infection Control/organization & administration, journalArticle, Laktash A, Male, Middle Aged, Obesity Morbid/complications/surgery, Obesity Surgery, Pandemics/prevention & control, Patient Selection, Pneumonia, Pneumonia Viral/epidemiology/prevention & control, Risk Factors, Rodriguez J, Safety, Schulz K, Wilson R
Ambulatory management of lower respiratory tract infections.
Tags: 1991, American family physician, Anti-Bacterial Agents/*therapeutic use, Bacterial Infections/drug therapy, Department of Internal Medicine, File T M Jr, Humans, Legionnaires' Disease/diagnosis, Mycoplasma/diagnosis, NEOMED College of Medicine, Pneumonia, Pneumonia/*diagnosis/*drug therapy, Tan J S, Thomson R B Jr
An update on the association of vitamin D deficiency with common infectious diseases.
Tags: 2015, Adaptive Immunity/immunology, Animals, Canadian journal of physiology and pharmacology, Communicable Diseases/*diagnosis/drug therapy/*immunology, Department of Internal Medicine, HIV, Humans, immunite, Immunity, Innate/immunology, Lemonovich Tracy L, MRSA, NEOMED College of Medicine, Pneumonia, pneumonie, Salata Robert A, SARM, sepsis, Sepsis/diagnosis/drug therapy/immunology, septicemie, therapy, traitement, VIH, Vitamin D, Vitamin D Deficiency/*diagnosis/drug therapy/*immunology, Vitamin D/*immunology/therapeutic use, vitamine D, Watkins Richard R
Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae.
Tags: *beta-Lactam Resistance, 2002, beta-Lactams/economics/*therapeutic use, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Contraindications, Department of Internal Medicine, File Thomas M Jr, Humans, NEOMED College of Medicine, Pneumococcal/*drug therapy/economics/pathology, Pneumonia, Practice Guidelines as Topic, Streptococcus pneumoniae/*drug effects/metabolism
Aspiration pneumonia, necrotizing pneumonia, and lung abscess.
Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials.
Tags: 2015, Adult, Aged, Anti-Bacterial Agents/*therapeutic use, Antimicrobial agents and chemotherapy, Anzueto Antonio R, Bacterial/*drug therapy, Ceftriaxone/*therapeutic use, Cephalosporins/*therapeutic use, Community-Acquired Infections/*drug therapy, Department of Internal Medicine, Female, File Thomas M, Huang Xingyue, Humans, Lodise Thomas P, Male, Middle Aged, NEOMED College of Medicine, Pneumonia, Shorr Andrew F, Smith Alexander, Treatment Outcome, Weber David J, Yang Min, Zhao Qi
Bacterial Pneumonia in Older Adults.
Tags: *Community-acquired, *Decision Making, *Elderly, *Etiology, *Pneumonia, *Risk factors, *Treatment, 2016, Aged, Bacterial – Epidemiology, Bacterial/*epidemiology, Clinics in geriatric medicine, Community-Acquired Infections – Epidemiology, Community-Acquired Infections/*epidemiology, Decision Making, Department of Internal Medicine, File Thomas M Jr, Global Health, Humans, Incidence, Marrie Thomas J, NEOMED College of Medicine, Pneumonia, Risk Factors, World Health
Burden of community-acquired pneumonia in North American adults.
Tags: 2010, Adult, Bacterial – Economics, Bacterial – Epidemiology, Bacterial – Microbiology, Bacterial – Mortality, Bacterial – Prevention and Control, Bacterial/economics/*epidemiology/microbiology/prevention & control, Community-Acquired Infections – Economics, Community-Acquired Infections – Epidemiology, Community-Acquired Infections – Microbiology, Community-Acquired Infections – Prevention and Control, Community-Acquired Infections/economics/epidemiology/microbiology/prevention & control, Cost of Illness, Department of Internal Medicine, Economic Aspects of Illness, File Thomas M Jr, Health Care Costs, Health Status Indicators, Hospitalization – Economics, Hospitalization – Statistics and Numerical Data, Hospitalization/economics/statistics & numerical data, Human, Humans, Incidence, Length of Stay – Statistics and Numerical Data, Length of Stay/statistics & numerical data, Marrie Thomas J, NEOMED College of Medicine, North America, North America/epidemiology, Pneumococcal Vaccine, Pneumococcal Vaccines, Pneumococcal/economics/epidemiology/mortality/prevention & control, Pneumonia, Postgraduate medicine, Risk Factors, Streptococcus, Streptococcus pneumoniae
Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.
Tags: 2016, Anti-Bacterial Agents/*therapeutic use, Bacterial/*drug therapy, Ceftriaxone/*therapeutic use, Cephalosporins/*therapeutic use, Community-Acquired Infections/*drug therapy, Department of Internal Medicine, File Thomas M, Friedland H David, Humans, Iaconis Joseph P, Llorens Lily, Melnick David, NEOMED College of Medicine, Pneumonia, Randomized Controlled Trials as Topic, Sun Fang, Taboada Maria, The Journal of antimicrobial chemotherapy, Wilson David, Zhong Nan Shan
Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia.
Tags: 2006, Anti-Infective Agents/*therapeutic use, Bacterial, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Community-Acquired Infections/*drug therapy/economics/*microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Fluoroquinolones/*therapeutic use, Humans, Ketolides/therapeutic use, Multiple, NEOMED College of Medicine, Pneumococcal/*drug therapy/economics/*microbiology, Pneumonia, Streptococcus pneumoniae/*growth & development
Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
Tags: *Levofloxacin, 2004, Administration, Adult, Anti-Bacterial Agents/*administration & dosage/economics, Bacterial/*drug therapy, Community-Acquired Infections/drug therapy, Current medical research and opinion, Department of Internal Medicine, Drug Administration Schedule, Drug Costs, Female, File Thomas M Jr, Humans, Infusions, Intravenous, Khashab Mohammed M, Male, Milkovich Gary, NEOMED College of Medicine, Ofloxacin/*administration & dosage/economics, Oral, Pneumonia, Tennenberg Alan M, Treatment Outcome, Xiang Jim X, Zadeikis Neringa
Community-acquired pneumonia: highlights of recent guidelines: how new recommendations may affect your practice.
Community-acquired pneumonia.
Tags: 2003, Antibiotics – Therapeutic Use, Bacterial, Bacterial – Diagnosis, Bacterial – Drug Therapy, Bacterial – Microbiology, Bacterial – Prevention and Control, Community-Acquired Infections, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Community-Acquired Infections – Prevention and Control, Department of Internal Medicine, Disease Progression, Drug Resistance, File T M Jr, Immunocompetence, Lancet, Microbial, NEOMED College of Medicine, Pneumonia, Severity of Illness, Streptococcus – Drug Effects, Vaccines – Therapeutic Use
Community-associated methicillin-resistant Staphylococcus aureas: not only a cause of skin infections, also a new cause of pneumonia.
Tags: *Methicillin Resistance, 2005, Anti-Bacterial Agents/pharmacology, Bacterial/*epidemiology/*microbiology, Community-Acquired Infections, Current opinion in infectious diseases, Department of Internal Medicine, File Thomas M Jr, Humans, NEOMED College of Medicine, Pneumonia, Staphylococcal Infections/*epidemiology, Staphylococcus aureus/*drug effects
Comparison of narrow-versus broad-spectrum antibiotics in elderly patients with acute exacerbations of chronic obstructive pulmonary disease
Tags: adults, Antibiotics, August 2020 List, chronic obstructive pulmonary disease, Damshekan N, Department of Pharmacy Practice, Elderly, exacerbations, Journal of pharmacy practice, journalArticle, Joyner KR, NEOMED College of Pharmacy, NEOMED College of Pharmacy Student, NEOMED Student Publications, neutrophil, Perry T, Pneumonia, Seidel K, society, Soric MM, Walkerly A, Walsh N
Disseminated Mycobacterium Haemophilum Infection And Pneumocystis Jirovecii Pneumonia In A Patient Receiving Immunosuppressive Therapy Case Report And Review Of Literature
Tags: 2019, Dalia Y, Diagnosis, Disease, disseminated Mycobacterium haemophilum, Fahmy J, HIV disease, Immunology, immunosuppressive therapy, Infectious Diseases, Infectious Diseases in Clinical Practice, Khoncarly S, manifestation, Moore T L, Myers J P, NEOMED College of Medicine Student, NEOMED Student Publications, pathogen, Pneumocystis jirovecii, Pneumonia, Rheumatoid arthritis, Transplant Recipients
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Tags: 2019, Administration Intravenous, Adult, Aged, Anti-Bacterial Agents/administration & dosage/adverse effects/therapeutic use, antibiotic, Clinical Infectious Diseases, Das A, Diterpenes/administration & dosage/adverse effects/therapeutic use, Double-Blind Method, Female, File TM, Gasink LB, Gelone SP, Goldberg L, Hospital List, Humans, journalArticle, lefamulin, Linezolid/adverse effects/therapeutic use, Male, Microbial Sensitivity Tests, Middle Aged, Moxifloxacin, Moxifloxacin/administration & dosage/adverse effects/therapeutic use, Paukner S, pleuromutilin, Pneumonia, Pneumonia Bacterial/drug therapy/metabolism, Polycyclic Compounds/administration & dosage/adverse effects/therapeutic use, Randomized Controlled Trials as Topic, Saviski J, Seltzer E, Sweeney C, Talbot GH, Thioglycolates/administration & dosage/adverse effects/therapeutic use, Wicha WW
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
Tags: 2012, a h1n1 virus, Antibacterial agents, Antiviral agents, asian influenza, Babinchak T, bacteremic pneumococcal, Bacterial, Community-acquired pneumonia, File T M, hong-kong influenza, Human, Infectious Diseases, Influenza, Influenza A, International Journal of Infectious Diseases, Journal Article or Conference Abstract Publication, Lode H, Masterton R G, Metersky M L, pandemic, Pneumonia, pregnant-women, randomized controlled-trial, respiratory-tract, streptococcus-pneumoniae, virus
Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-Acquired Pneumonia in Hospitalized US Adults.
Tags: 20-valent pneumococcal conjugate vaccine, 2021, Adult, Alexander-Parrish R, Clinical Infectious Diseases, Counselman F, Department of Internal Medicine, File T, Ford KD, Grant L, Gray S, Isturiz R, Jiang Qin, Jodar L, journalArticle, May 2021 List, NEOMED College of Medicine, Ostrosky-Zeichner L, Overcash JS, Peyrani P, Pneumonia, Pride MW, Ramirez J, Self Wesley H, serotypes, Sherwin R, urinary antigen detection, Volturo G, Wunderink RG
Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-Acquired Pneumonia in Hospitalized US Adults.
Extracorporeal Membrane Oxygenation in Extreme Obesity: A Case Report and Review of the Literature.
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
Tags: 2011, 80 and over, Aged, Bacteria, Bacteria/isolation & purification, Bacterial – Drug Therapy, Bacterial/*drug therapy, Ceftriaxone – Administration and Dosage, Ceftriaxone – Adverse Effects, Ceftriaxone/administration & dosage/adverse effects, Cephalosporins – Administration and Dosage, Cephalosporins – Adverse Effects, Cephalosporins/*administration & dosage/*adverse effects, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections/*drug therapy, Critchley Ian A, Department of Internal Medicine, Double-Blind Method, Double-Blind Studies, Eckburg Paul B, Female, File Thomas M Jr, Friedland H David, Human, Humans, Infusions, Intravenous, Lee Jon, Llorens Lily, Low Donald E, Male, Middle Age, Middle Aged, NEOMED College of Medicine, Pneumonia, RANDOMIZED controlled trials, Talbot George H, The Journal of antimicrobial chemotherapy, Thye Dirk A, Treatment Outcome, Treatment Outcomes
Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
Tags: 2007, 80 and over, Adolescent, Adult, Aged, Anti-Bacterial Agents/*administration & dosage/adverse effects/therapeutic use, Bacterial/*drug therapy/microbiology, Community-Acquired Infections/*drug therapy/microbiology, Department of Internal Medicine, Double-Blind Method, Drug Administration Schedule, Female, File Thomas M Jr, Fluoroquinolones/*administration & dosage/adverse effects/therapeutic use, Gemifloxacin, Georgiev Ognian, Humans, Kostov Kosta, Male, Mandell Lionel A, Middle Aged, Naphthyridines/*administration & dosage/adverse effects/therapeutic use, NEOMED College of Medicine, Pneumococcal/drug therapy/microbiology, Pneumonia, Streptococcus pneumoniae/isolation & purification, The Journal of antimicrobial chemotherapy, Tillotson Glenn, Treatment Outcome
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Tags: 2004, Bacterial, Bacterial/*drug therapy, Blasi Francesco, Canada, Chest, Chidiac Christian, Community-Acquired Infections/drug therapy, Department of Internal Medicine, Drug Resistance, Europe, File Thomas M Jr, Fluoroquinolones/therapeutic use, Garau Javier, Humans, Klugman Keith, Lactams/therapeutic use, Lode Hartmut, Lonks John R, Macrolides/therapeutic use, Mandell Lionel, NEOMED College of Medicine, Pneumonia, Practice Guidelines as Topic, Ramirez Julio, United States, Yu Victor
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Tags: 2004, Antibiotics, Antibiotics – Administration and Dosage, Antiinfective Agents, Bacterial – Drug Therapy, Blasi F, Canada, Chest, Chidiac C, Community-Acquired Infections – Drug Therapy, Comparative Studies, Department of Internal Medicine, Drug Resistance, Europe, File T M Jr, Fluoroquinolone – Therapeutic Use, Garau J, Klugman K, Lactam – Therapeutic Use, Lode H, Lonks JR, Macrolide – Therapeutic Use, Mandell L, Microbial, NEOMED College of Medicine, Pneumonia, Practice Guidelines, Ramirez J, United States, Yu V
Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
Tags: 2009, changing epidemiology, Community-acquired, Community-acquired pneumonia, conjugate vaccine, Farley M M, File T M, General & Internal Medicine, H1N1 influenza, Hall W J, Hopkins R, invasive pneumococcal disease, Journal Article, Levine O S, Meningitis, Nichol K L, Nuorti P, older-adults, pneumococcal disease, Pneumonia, Postgraduate medicine, PPSV23, Rehm S J, Schaffner W, united-states, Zimmerman R K
Identifying Barriers to Adult Pneumococcal Vaccination: An NFID Task Force Meeting
Tags: 2012, adult vaccination, care, Disease, File T M, General & Internal Medicine, Influenza, Journal Article, Metersky M, Natl Fdn Infect Dis Pneumococcal D, Nichol K L, pneumococcal disease, Pneumococcal Vaccine, Pneumonia, Postgraduate medicine, Rehm S J, Schaffner W, Streptococcus pneumoniae, united-states
Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
Tags: 2010, 80 and over, Administration, Adult, Aged, Anti-Bacterial Agents/*administration & dosage/*adverse effects, Bacterial/*drug therapy, Ceftriaxone/*administration & dosage/*adverse effects, Cephalosporins/*administration & dosage/*adverse effects, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Community-Acquired Infections/drug therapy, Critchley Ian, Department of Internal Medicine, Double-Blind Method, Eckburg Paul B, Female, File Thomas M Jr, Friedland H David, Humans, Infusions, Intravenous, Lee Jon, Llorens Lily, Low Donald E, Male, Middle Aged, NEOMED College of Medicine, Oral, Pneumonia, Talbot George H, Thye Dirk, Treatment Outcome
International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
Tags: 2003, Adjuvants, Adult, Anti-Infective Agents/*therapeutic use, Bacterial, Bacterial/*drug therapy/microbiology, Clinical Trials as Topic, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, Drug Resistance, Drugs, File Thomas M Jr, Humans, Immunologic/pharmacology/therapeutic use, Inpatients, Macrolides/pharmacology/*therapeutic use, Microbial Sensitivity Tests, NEOMED College of Medicine, Outpatients, Pneumonia, Practice Guidelines as Topic, Tan James S, Treatment Failure
LVC Timing in Infant Pig Swallowing and the Effect of Safe Swallowing.
Tags: *Animal model, *Aspiration, *Deglutition, *Deglutition disorders, *Dysphagia, *Infant, *Laryngeal vestibule closure, *Recurrent laryngeal nerve, 2018, Animal, Animal Population Groups, Animals, Aspiration – Etiology, Aspiration/*etiology, Biological, Deglutition – Physiology, Deglutition Disorders – Etiology, Deglutition Disorders/*etiology, Deglutition/*physiology, Department of Anatomy & Neurobiology, Disease Models, Dysphagia, German Rebecca, Gould Francois, Gross Andrew, Humans, Laryngeal Nerve Injuries/*complications, Laryngeal Nerves – Injuries, Larynx, Models, NEOMED College of Medicine, Newborn, Ohlemacher Jocelyn, Oropharynx, Pneumonia, Questionnaires, Swine
Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
Tags: 2017, 80 and over, Adult, Aged, Anti-Bacterial Agents/adverse effects/*therapeutic use, Atypical pathogen, Bacterial/*drug therapy, Ceftaroline fosamil, Ceftriaxone/adverse effects/*therapeutic use, Cephalosporins/adverse effects/*therapeutic use, Chlamydial Pneumonia, Chlamydophila pneumoniae, Clinical Trials, Combination/adverse effects/methods, Community-Acquired Infections/*drug therapy, Community-acquired pneumonia, Department of Internal Medicine, Double-Blind Method, Drug Therapy, Eckburg Paul B, Female, File Thomas M Jr, Friedland H David, Humans, International journal of antimicrobial agents, Legionella pneumophila, Llorens Lily, Macrolide, Macrolides/adverse effects/*therapeutic use, Male, Middle Aged, Mycoplasma, Mycoplasma pneumoniae, NEOMED College of Medicine, Phase III as Topic, Pneumonia, Randomized Controlled Trials as Topic, Talbot George H, Time Factors, Treatment Outcome
Management of community-acquired pneumonia: a focus on conversion from hospital to the ambulatory setting.
Tags: *Ambulatory Care, *Hospitalization, 2003, American journal of respiratory medicine : drugs, devices, and other interventions, Anti-Bacterial Agents/*administration & dosage, Bacterial/*therapy, Community-Acquired Infections/therapy, Department of Internal Medicine, File Thomas M Jr, Humans, NEOMED College of Medicine, Pneumonia, Tan James S
Management Of Community-acquired Pneumonia: An Appropriate-use Tool
Tags: 2001, adults, Antimicrobial resistance, azithromycin, Bartlett J G, Bernstein A, Community-acquired, File T M, guidelines, Infections in Medicine, Infectious Diseases, Levofloxacin, Martinez F J, outcomes, Pneumonia, resistant streptococcus-pneumoniae, surveillance, therapy, Treatment, united-states
Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem
Tags: 2004, acute exacerbation, acute otitis media, airway inflammation, Antimicrobial resistance, chronic bronchitis, chronic obstructive, Community-acquired pneumonia, Current medical research and opinion, Disease, empiric therapy, File T M, General & Internal Medicine, haemophilus-influenzae, Journal Article, moraxella-catarrhalis, obstructive-pulmonary-disease, pneumococcal, Pneumonia, pulmonary, Research & Experimental Medicine, resistance, resistant streptococcus-pneumoniae, Sethi S, surveillance program
New diagnostic tests for pneumonia: what is their role in clinical practice?
Tags: 2011, Antigens, Bacterial/*diagnosis/metabolism, Bacterial/urine, Calcitonin/blood, Clinics in chest medicine, Community-Acquired Infections/*diagnosis/metabolism/*microbiology/virology, Department of Internal Medicine, File Thomas M Jr, Humans, NEOMED College of Medicine, Nucleic Acid Amplification Techniques, Pneumonia, Polymerase Chain Reaction, Protein Precursors/blood, Viral/*diagnosis/metabolism
New Diagnostic Tests for Pneumonia: What is Their Role in Clinical Practice?
Tags: 2011, Antigens, Bacterial – Diagnosis, Bacterial – Metabolism, Bacterial – Urine, Calcitonin – Blood, Clinics in chest medicine, Community-Acquired Infections, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Metabolism, Community-Acquired Infections – Microbiology, Department of Internal Medicine, File T M Jr, NEOMED College of Medicine, Nucleic Acid Amplification Techniques, Pneumonia, Polymerase Chain Reaction, Protein Precursors – Blood, Viral – Diagnosis, Viral – Metabolism